📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

P153 Tocilizumab in systemic sclerosis: real world experience from a single centre cohort supports potential benefit on lung function for anti-topoisomerase (Scl-70) positive subgroup (2020)

First Author: Denton C

Attributed to: Functional and molecular diversity of skin fibroblasts in systemic sclerosis. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keaa111.148

Publication URI: http://dx.doi.org/10.1093/rheumatology/keaa111.148

Type: Journal Article/Review

Parent Publication: Rheumatology

Issue: Supplement_2